Your browser doesn't support javascript.
loading
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains.
Broecker, Felix; Liu, Sean T H; Suntronwong, Nungruthai; Sun, Weina; Bailey, Mark J; Nachbagauer, Raffael; Krammer, Florian; Palese, Peter.
Affiliation
  • Broecker F; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
  • Liu STH; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
  • Suntronwong N; 2Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Sun W; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
  • Bailey MJ; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
  • Nachbagauer R; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
  • Krammer F; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
  • Palese P; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
NPJ Vaccines ; 4: 31, 2019.
Article in En | MEDLINE | ID: mdl-31341648

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Vaccines Year: 2019 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Vaccines Year: 2019 Document type: Article Country of publication: